Management of pruritus in patients with cholestatic liver disease

Gastroenterology and Hepatology

Volumn 7, Issue 9, 2011, Pages 615-617

  Levy, Cynthia ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; NALOXONE; NALTREXONE; RIFAMPICIN; URSODEOXYCHOLIC ACID;

ALBUMIN DIALYSIS; BLOATING; CHOLESTASIS; CONSTIPATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MEDICAL RESEARCH; NAUSEA; NOTE; PRACTICE GUIDELINE; PRIMARY BILIARY CIRRHOSIS; PRURITUS; TREATMENT OUTCOME;

EID: 81855186987     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology. 2009;50:291-308.
2. Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008-1018.
3. Oude Elferink RP, Kremer AE, Beuers U. Mediators of pruritus during cholestasis. Curr Opin Gastroenterol. 2011;27:289-293.
4. Parés A, Herrera M, Avilés J, Sanz M, Mas A. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from 3 centers. J Hepatol. 2010;53:307-312.
5. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162:587-593.